Cell of origin for malignant gliomas and its implication in therapeutic development.

Malignant glioma remains incurable despite tremendous advancement in basic research and clinical practice. The identification of the cell(s) of origin should provide deep insights into leverage points for one to halt disease progression. Here we summarize recent studies that support the notion that neural stem cell (NSC), astrocyte, and oligodendrocyte precursor cell (OPC) can all serve as the cell of origin. We also lay out important considerations on technical rigor for further exploring this subject. Finally, we share perspectives on how one could apply the knowledge of cell of origin to develop effective treatment methods. Although it will be a difficult battle, victory should be within reach as along as we continue to assimilate new information and facilitate the collaboration among basic scientists, translational researchers, and clinicians. Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Citation

Hui Zong, Luis F Parada, Suzanne J Baker. Cell of origin for malignant gliomas and its implication in therapeutic development. Cold Spring Harbor perspectives in biology. 2015 May;7(5)

Mesh Tags

PMID: 25635044

search → result